Cargando…

International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study

BACKGROUND: Although angina is common in patients with stable coronary artery disease, limited data are available on its prevalence, natural evolution, and outcomes in the era of effective cardiovascular drugs and widespread use of coronary revascularization. METHODS: Using data from 32 691 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mesnier, Jules, Ducrocq, Gregory, Danchin, Nicolas, Ferrari, Roberto, Ford, Ian, Tardif, Jean-Claude, Tendera, Michal, Fox, Kim M., Steg, Philippe Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360663/ https://www.ncbi.nlm.nih.gov/pubmed/34261331 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054567

Ejemplares similares

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017)

Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2018)

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015)

Use of risk scores to identify lower and higher risk subsets among COMPASS‐eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry
por: Darmon, Arthur, et al.
Publicado: (2020)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2019)

Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
por: Sorbets, Emmanuel, et al.
Publicado: (2020)

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012)

β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
por: Sorbets, Emmanuel, et al.
Publicado: (2019)

Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
por: Ford, Ian, et al.
Publicado: (2020)

Management and clinical outcome of stable coronary artery disease in Austria: Results from 5 years of the CLARIFY registry
por: Lang, Irene M., et al.
Publicado: (2017)

Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients
por: Kalra, Paul R., et al.
Publicado: (2014)

Stable Angina
por: Dobesh, Paul P.
Publicado: (2006)

Management of a patient with chronic stable angina
por: Fox, Kim
Publicado: (2019)

Role of ivabradine in management of stable angina in patients with different clinical profiles
por: Kaski, Juan Carlos, et al.
Publicado: (2018)

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
por: Ducrocq, Gregory, et al.
Publicado: (2010)

Ivabradine: the evidence of its therapeutic impact in angina
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2008)

Investigation and Management of Stable Angina
por: Underwood, Richard, et al.
Publicado: (1993)

Investigation and Management of Stable Angina
por: Clarke, S E M
Publicado: (1993)

Advances in the Management of Stable Angina
por: Trujillo, Toby C.
Publicado: (2006)

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
por: Tardif, Jean-Claude, et al.
Publicado: (2009)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Urine proteomics in the diagnosis of stable angina
por: Neisius, Ulf, et al.
Publicado: (2016)

Coronary revascularization in the elderly with stable angina
por: Kozlov, Kirill Lenarovich, et al.
Publicado: (2015)

Re chronic stable angina guidelines
por: Gupta, Prabha Nini, et al.
Publicado: (2017)

Impact of angina frequency on health utility values of patients with chronic stable angina
por: Kohn, Christine G, et al.
Publicado: (2014)

Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
por: Eisen, Alon, et al.
Publicado: (2016)

Risk factors in blood for attacks of angina in patients with coronavirus disease 2019 and stable angina
por: Geng, Song, et al.
Publicado: (2023)

Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008)

Effectiveness of Ivabradine in Treating Stable Angina Pectoris
por: Ye, Liwen, et al.
Publicado: (2016)

Ivabradine for the Therapy of Chronic Stable Angina Pectoris
por: Kim, Soo-Joong
Publicado: (2020)

Bony labyrinth morphology clarifies the origin and evolution of deer
por: Mennecart, Bastien, et al.
Publicado: (2017)

Carvedilol modifies antioxidant status of patients with stable angina
por: Kowalski, Jan, et al.
Publicado: (2008)

Not So Stable Angina: Single Coronary Artery Disease
por: Thangjui, Sittinun, et al.
Publicado: (2022)

The Material Basis and Mechanism of Xuefu Zhuyu Decoction in Treating Stable Angina Pectoris and Unstable Angina Pectoris
por: Qi, Guanpeng, et al.
Publicado: (2022)

Treating angina
por: Ferrari, Roberto, et al.
Publicado: (2019)

EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
por: Picard, Fabien, et al.
Publicado: (2019)

The multifaceted angina
por: Ferrari, Roberto, et al.
Publicado: (2019)

Complete Genomes of Symbiotic Cyanobacteria Clarify the Evolution of Vanadium-Nitrogenase
por: Nelson, Jessica M, et al.
Publicado: (2019)

Early cephalopod evolution clarified through Bayesian phylogenetic inference
por: Pohle, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fth2sbl61btkdqkeq9lkhqa9e4